NCT05470595: A Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung
- State
- Under way
- Phase
- Phase 2
- People
- 67 planned
- Started
- 18 Jan 2022
- Primary completion
- 31 Jan 2028
- Arms
- Atezolizumab/Platinum/Etoposide
- Results
- None posted
- 18 Jan 2022: Trial started
- 22 Jul 2022: Trial registered